SynthesisBMC neurology2026
Prevalence and incidence of transient ischaemic attack: a systematic review and meta-analysis.
Synthesis in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundTransient ischaemic attack (TIA) is a strong predictor of stroke, has a high risk of recurrence, and may lead to a variety of sequelae. The purpose of this study was to understand the epidemiological characteristics and trends of TIA through a systematic review and meta-analysis, to identify high-risk populations, and to provide a basis for prevention and intervention measures.
methodsFollowing the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 guidelines, we searched Chinese-language (CNKI, Wanfang, VIP, and CBM) and English-language databases (PubMed, Cochrane, Embase, and Web of Science) from inception to October 25, 2024. Cross-sectional or cohort studies reporting the prevalence or incidence of TIA were included. Quality assessment was performed using the AHRQ and NOS scales. Data synthesis was performed with Stata 17.0, employing a random-effects model for high heterogeneity (I² > 50%). Subgroup analyses were conducted on the basis of region, publication year, gender, age and diagnostic criteria.
resultsFrom 20,114 screened records, 47 studies were included, contributing a total of 50 datasets for analysis (23 for prevalence and 27 for incidence). The global pooled prevalence of TIA was 1.95% (95% CI: 1.27-2.77%), and the prevalence was elevated in Asia (2.19%) and among older adults (> 65 years, 5.13%). The annual incidence was 54 per 100,000 person-years, with the highest incidence occurring in the Americas (81 per 100,000). No significant gender differences were found in terms of prevalence or incidence. The incidence decreased over time but increased with age. The use of imaging-based criteria is associated with a lower and likely more accurate estimation of TIA prevalence.
conclusionThis study provides updated global estimates of TIA epidemiology, revealing significant variations influenced by diagnostic criteria, age, and region. The substantial heterogeneity and potential underreporting highlight the need for standardized, imaging-based diagnostic protocols in future research. The development of precise risk stratification tools and region-specific prevention strategies is imperative for mitigating the global burden of TIA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.